USE OF UROCORTIN III AND UROCORTIN I AS THERAPEUTIC AGENTS

摘要

The present invention is directed to the use of the combination of the Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-lle-Met-Asn-Leu-Leu-Phe-Asn-lle-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-lle-NH2 and Asp-Asn-Pro-Ser-Leu-Ser-lle-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-lle-lle-Phe-Asp-Ser-Val-NH2 as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease.